var data={"title":"Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/contributors\" class=\"contributor contributor_credentials\">Hans H Hirsch, MD, MSc</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/contributors\" class=\"contributor contributor_credentials\">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/contributors\" class=\"contributor contributor_credentials\">Anna R Thorner, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 12, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H87574322\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Polyomavirus infections have been detected in vertebrate hosts including rodents, cattle, birds, monkeys, and primates. Despite some common features with papillomaviruses, including an oncogenic potential, polyomaviruses are recognized as members of the separate genus <em>Polyomavirus</em> in the Polyomaviridae family of the ungrouped DNA viruses [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/1\" class=\"abstract_t\">1</a>].</p><p>An overview of the disease associations, clinical manifestations, and diagnosis of polyomavirus infections will be provided here. The virology, epidemiology, and pathogenesis of infections with human polyomaviruses will be presented separately. Progressive multifocal leukoencephalopathy and BK polyomavirus-associated nephropathy and ureteral stenosis are also discussed in detail elsewhere. (See <a href=\"topic.htm?path=virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses\" class=\"medical medical_review\">&quot;Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses&quot;</a> and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=natalizumab-for-relapsing-remitting-multiple-sclerosis-in-adults#H4\" class=\"medical medical_review\">&quot;Natalizumab for relapsing-remitting multiple sclerosis in adults&quot;, section on 'Risk of PML'</a> and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-treatment-and-prognosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Treatment and prognosis&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=ureteral-stenosis-due-to-bk-virus-infection-among-kidney-transplant-recipients\" class=\"medical medical_review\">&quot;Ureteral stenosis due to BK virus infection among kidney transplant recipients&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H190971454\"><span class=\"h1\">DISEASE ASSOCIATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most immunocompetent individuals with primary polyomavirus infections have a subclinical or nonspecific influenza-like course. In immunocompromised individuals, however, human polyomavirus (HPyV) replication can cause specific syndromes and lead to substantial morbidity. Some HPyV-associated diseases are more frequently encountered in specific patient populations, suggesting that the interaction of patient, organ, and virus determinants underlie the pathogenesis; the reasons for these associations are not fully understood [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>BK polyomavirus</strong> &ndash; BK polyomavirus (BKPyV) may cause nephropathy and, less commonly, ureteric stenosis in kidney transplant recipients (and rarely in recipients of other types of transplants) [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/3,4\" class=\"abstract_t\">3,4</a>]. BKPyV also causes hemorrhagic cystitis, primarily in allogeneic hematopoietic cell transplant recipients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/2,5\" class=\"abstract_t\">2,5</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=ureteral-stenosis-due-to-bk-virus-infection-among-kidney-transplant-recipients\" class=\"medical medical_review\">&quot;Ureteral stenosis due to BK virus infection among kidney transplant recipients&quot;</a> and <a href=\"topic.htm?path=overview-of-infections-following-hematopoietic-cell-transplantation#H12425433\" class=\"medical medical_review\">&quot;Overview of infections following hematopoietic cell transplantation&quot;, section on 'Hemorrhagic cystitis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>JC polyomavirus</strong> &ndash; JC polyomavirus (JCPyV) may cause progressive multifocal leukoencephalopathy in immunocompromised patients, such as those with advanced HIV infection, hematologic malignancies, and those receiving lymphocyte-targeted therapies for autoimmune diseases (eg, <a href=\"topic.htm?path=natalizumab-drug-information\" class=\"drug drug_general\">natalizumab</a>). It rarely causes JCPyV-associated nephropathy [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-treatment-and-prognosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Treatment and prognosis&quot;</a> and <a href=\"topic.htm?path=natalizumab-for-relapsing-remitting-multiple-sclerosis-in-adults#H4\" class=\"medical medical_review\">&quot;Natalizumab for relapsing-remitting multiple sclerosis in adults&quot;, section on 'Risk of PML'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Merkel cell polyomavirus</strong> &ndash; Merkel cell polyomavirus (MCPyV) has been associated with Merkel cell carcinoma in sun-exposed skin of older adult patients who often have received longstanding immunosuppression. It may be a frequent colonizer of healthy skin [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-merkel-cell-neuroendocrine-carcinoma#H5\" class=\"medical medical_review\">&quot;Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma&quot;, section on 'Merkel cell polyomavirus'</a>.)</p><p/><p class=\"bulletIndent1\">An association between MCPyV seroconversion and tonsillitis <span class=\"nowrap\">and/or</span> lymphadenopathy (but not acute respiratory tract infection) has been observed in children [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/8\" class=\"abstract_t\">8</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>KI and WU viruses</strong> &ndash; KI polyomavirus and WU polyomavirus have been detected in respiratory specimens, but it remains unclear whether they play a role in respiratory tract disease [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/9-12\" class=\"abstract_t\">9-12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Human polyomavirus 7</strong> &ndash; Human polyomavirus 7 has been associated with a pruritic rash and viremia in lung transplant recipients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>TS polyomavirus</strong> &ndash; TS polyomavirus causes trichodysplasia spinulosa, a rare skin disease in immunocompromised hosts, characterized by follicular papules, keratin spines known as spicules, and alopecia [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/14-16\" class=\"abstract_t\">14-16</a>]. (See <a href=\"#H702780718\" class=\"local\">'Trichodysplasia spinulosa'</a> below.)</p><p/><p>Information about other human polyomavirus infections, such as human polyomaviruses 6, 9, 10, 11, and 13, is still scant. These viruses are discussed separately. (See <a href=\"topic.htm?path=virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses#H3730951\" class=\"medical medical_review\">&quot;Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses&quot;, section on 'Classification'</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infection with JC polyomavirus (JCPyV) or BK polyomavirus (BKPyV) is common, but significant clinical manifestations are rare in immunocompetent hosts. Although symptomatic primary infection may occur with either of these viruses, the major clinical manifestations result from reactivation of replicative viral disease in immunocompromised individuals.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Primary infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Antibodies against JCPyV and BKPyV in adults are common, suggesting past exposure and persisting infection with latency in the renourinary tract. However, little is known about the clinical manifestations of primary infection with these viruses. It is thought that the majority of primary infections are asymptomatic or cause a nonspecific influenza-like illness [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/17\" class=\"abstract_t\">17</a>] (see <a href=\"topic.htm?path=virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses#H516190899\" class=\"medical medical_review\">&quot;Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses&quot;, section on 'Seroprevalence by age'</a>). However, primary infection post-transplant may result in polyomavirus (PyV)-associated nephropathy.</p><p>Serologic evidence for acute BKPyV infection was documented in 8 percent of children with upper respiratory tract illnesses [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/17\" class=\"abstract_t\">17</a>]. There are few data on primary infection with the other human polyomaviruses. As noted above, an association between MC polyomavirus seroconversion and tonsillitis <span class=\"nowrap\">and/or</span> lymphadenopathy (but not acute respiratory tract infection) has been observed in children [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/8\" class=\"abstract_t\">8</a>]. (See <a href=\"#H190971454\" class=\"local\">'Disease associations'</a> above.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Viruria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Detection of PyV DNA in the urine is thought to be a sign of active virus replication, which may occur at low levels in immunocompetent people; higher levels of viruria are seen in immunocompromised hosts. Decoy cells found on urine cytology are a marker of high-level viruria caused by BKPyV or JCPyV corresponding to urine viral loads of more than 7 log<sub>10</sub> <span class=\"nowrap\">copies/mL</span> [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Transplant recipients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Guidelines have been published covering aspects of polyomavirus infection, replication, and disease following kidney transplantation [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/18\" class=\"abstract_t\">18</a>], transplantation of other solid organs [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/19\" class=\"abstract_t\">19</a>], and hematopoietic stem cell transplantation [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/20,21\" class=\"abstract_t\">20,21</a>]. BK viruria increases in prevalence and magnitude (ie, viral load) in immunocompromised patients. After kidney transplantation, high-level viruria, defined as urine BKPyV loads &gt;7 log<sub>10</sub> <span class=\"nowrap\">copies/mL,</span> or shedding of urothelial or tubular epithelial cells with cytopathologic changes (&quot;decoy cells&quot;) is seen in 30 to 60 percent of patients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/22-26\" class=\"abstract_t\">22-26</a>]. However, only one-third of patients with BK viruria develop BK viremia and nephropathy [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/23,25,27,28\" class=\"abstract_t\">23,25,27,28</a>].</p><p>In solid organ transplant recipients other than kidney, viruria is seen in approximately 15 percent of patients, and median urine viral loads are typically lower than in kidney transplant recipients, at around 6 log<sub>10</sub> <span class=\"nowrap\">copies/mL</span> [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/3,29-31\" class=\"abstract_t\">3,29-31</a>]. However, in the few cases of proven BKPyV-associated nephropathy in solid organ transplant recipients other than kidney, similarly high urine and plasma BKPyV loads have been documented [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a>.)</p><p>BK viruria occurs in approximately 50 to 90 percent of patients after hematopoietic cell transplantation (HCT), usually within the first two months post-transplant [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/5,32-34\" class=\"abstract_t\">5,32-34</a>]. It is thought that viruria in these patients represents reactivation of latent infection in the HCT recipient, since virus shedding has been described typically in patients who were seropositive before transplantation [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/3,5,35\" class=\"abstract_t\">3,5,35</a>]. However, data from pediatric HCT recipients suggest that de novo infection in seronegative children might occur in some cases [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/36\" class=\"abstract_t\">36</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">HIV-infected patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HIV-infected patients with low CD4 counts have a higher incidence of BK viruria and also shed BKPyV at higher levels than HIV-infected patients with high CD4 counts or immunocompetent individuals; this difference is less pronounced for JC viruria [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/37,38\" class=\"abstract_t\">37,38</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Systemic lupus erythematosus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with systemic lupus erythematosus (SLE) have a high prevalence of asymptomatic BK viruria (16 versus 0 percent in healthy individuals by polymerase chain reaction [PCR] in one report) [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/39\" class=\"abstract_t\">39</a>]. In addition, 16 of 20 patients (80 percent) followed for at least one year excreted PyV in the urine (BKPyV in 13 patients; JCPyV in 3 patients). Although immunosuppressive therapy was not temporally associated with viruria, BKPyV viruria was not analyzed at the time of first diagnosis and prior to any treatment, suggesting that a significant proportion of patients had been exposed to therapy at the time of testing.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Pregnancy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Asymptomatic JC or BK viruria can be detected by cytology in approximately 3 percent of pregnant women [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/40\" class=\"abstract_t\">40</a>]. BKPyV shedding occurs primarily during the third trimester and usually ceases during the immediate postpartum period [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/41,42\" class=\"abstract_t\">41,42</a>]. Viruria probably represents reactivation of previously acquired infection since studies have demonstrated high JC and BK seroprevalence rates but no evidence of seroconversions.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Healthy individuals</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>BK viruria can be detected intermittently in up to 10 percent of healthy asymptomatic individuals at viral loads of approximately 5000 <span class=\"nowrap\">copies/mL</span> [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/43\" class=\"abstract_t\">43</a>]. JC viruria is more prevalent than BK viruria and is detectable in 10 to 30 percent of healthy people at urine viral loads of approximately 50,000 <span class=\"nowrap\">copies/mL</span>. The detection of BKPyV or JCPyV in the urine indicates infection, but detection of viruria is not sufficient to diagnose PyV-associated diseases. Merkel cell polyomavirus (MCPyV) can be detected in the urine of healthy donors (and kidney transplant recipients), but rates and viral loads are low, close to the level of detection of the assay.</p><p class=\"headingAnchor\" id=\"H101903165\"><span class=\"h2\">Viremia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The detection of BKPyV DNA in the blood has been found to be a marker of PyV-associated nephropathy in kidney transplant recipients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/44\" class=\"abstract_t\">44</a>] and, in a prospective study, correlated with the onset and resolution of disease [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/23\" class=\"abstract_t\">23</a>].</p><p>In transplant recipients other than kidneys, viremia with BKPyV or JCPyV is rare and usually of low level and without evidence for disease [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/45\" class=\"abstract_t\">45</a>]. In a study of 263 solid organ transplant recipients, viremia with BKPyV was observed in 26 percent of kidney transplant recipients and less frequently in heart (7 percent) or liver (4 percent) transplant recipients during the first year following transplantation [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/46\" class=\"abstract_t\">46</a>]. Viremia with JCPyV was observed in 20 percent of kidney-pancreas transplant recipients, 8 percent of kidney transplant recipients, 7 percent of heart transplant recipients, and 2 percent of liver transplant recipients during the first year following transplantation. The majority of active infections were subclinical. In another study, renal or liver transplant recipients did not have any evidence of BK or JC viremia, although a significant proportion had asymptomatic viruria detected by PCR [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/3,45\" class=\"abstract_t\">3,45</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a>.)</p><p>Viremia with either BKPyV or JCPyV is rare in HIV-infected patients, including those with progressive multifocal encephalopathy (PML) [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/44,47\" class=\"abstract_t\">44,47</a>] or in HIV-infected patients without PML matched for gender and CD4+ T cell count [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/48\" class=\"abstract_t\">48</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Progressive multifocal leukoencephalopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>JCPyV is the main causative agent of PML, a demyelinating disorder that almost always occurs in the setting of immunocompromise. PML has been reported most commonly in patients with advanced HIV (particularly before the availability of antiretroviral therapy [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/49\" class=\"abstract_t\">49</a>]), but it has also been reported in patients with hematologic malignancies and in patients receiving certain lymphocyte-targeted agents, such as <a href=\"topic.htm?path=natalizumab-drug-information\" class=\"drug drug_general\">natalizumab</a> [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/50\" class=\"abstract_t\">50</a>]. (See <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis#H2\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;, section on 'Epidemiology'</a> and <a href=\"topic.htm?path=natalizumab-for-relapsing-remitting-multiple-sclerosis-in-adults#H4\" class=\"medical medical_review\">&quot;Natalizumab for relapsing-remitting multiple sclerosis in adults&quot;, section on 'Risk of PML'</a>.)</p><p>Patients with PML typically present with rapidly progressive focal neurologic deficits without signs of increased intracranial pressure. Ataxia, hemiparesis, visual field deficits, and cognitive impairment are common presenting findings; aphasia <span class=\"nowrap\">and/or</span> cranial nerve deficits can also occur. Seizures are rare in HIV-infected patients with PML but have been encountered more frequently during immune reconstitution following antiretroviral therapy and in patients developing PML under immunosuppressive therapy for autoimmune disorders, suggesting that local inflammation linked to residual immune function may be a contributory factor. (See <a href=\"topic.htm?path=virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses#H3730986\" class=\"medical medical_review\">&quot;Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses&quot;, section on 'Pathogenesis'</a>.)</p><p>The epidemiology, clinical manifestations, diagnosis, and treatment of PML are discussed in detail elsewhere. (See <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-treatment-and-prognosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Treatment and prognosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H190971468\"><span class=\"h2\">Nephropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>BKPyV is the main causative agent of PyV-associated nephropathy in renal transplant recipients, which presents as progressive renal dysfunction resulting in either an asymptomatic acute or slowly progressive rise in serum creatinine [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/4\" class=\"abstract_t\">4</a>]. The disease progresses through defined histologic stages with cytopathic changes and little inflammation early (stage A) to pronounced cytopathic-inflammatory pathology also called tubulointerstitial nephritis (stage B), to a late presentation with interstitial fibrosis and tubular atrophy (stage C); more advanced disease is associated with an increased risk of renal allograft loss [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/4,51\" class=\"abstract_t\">4,51</a>]. Rare cases are due to JCPyV and may be due to primary infection in some cases [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/6,52\" class=\"abstract_t\">6,52</a>]. BKPyV-associated nephropathy is rare in transplant patients other than kidneys [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/3,53\" class=\"abstract_t\">3,53</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H190971498\"><span class=\"h2\">Ureteral stenosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>BKPyV can cause ureter stenosis in kidney transplant recipients, due at least in part to its tropism for renourinary epithelium. Patients with ureteral stenosis due to BKPyV present with symptoms <span class=\"nowrap\">and/or</span> signs of urinary tract obstruction, particularly an increase in serum creatinine. Since the transplanted kidney is not innervated, the pain and discomfort that may be observed in nontransplant patients with nephritis are typically absent. (See <a href=\"topic.htm?path=ureteral-stenosis-due-to-bk-virus-infection-among-kidney-transplant-recipients\" class=\"medical medical_review\">&quot;Ureteral stenosis due to BK virus infection among kidney transplant recipients&quot;</a>.)</p><p>Ureteral stenosis due to BKPyV has been reported rarely in HCT recipients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/54,55\" class=\"abstract_t\">54,55</a>]. In one report, an HCT recipient with BKPyV infection developed hemorrhagic cystitis followed by bilateral ureteral stenosis [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/54\" class=\"abstract_t\">54</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Hemorrhagic cystitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute hemorrhagic cystitis following engraftment among HCT recipients may be associated with BKPyV infection. In a review of 53 HCT recipients who were monitored prospectively, BK viruria was documented in 55 percent of specimens during episodes of cystitis compared with only 8 to 11 percent of specimens during cystitis-free periods [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/5\" class=\"abstract_t\">5</a>]. Similar findings were observed in another study [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/56\" class=\"abstract_t\">56</a>]. Furthermore, among 19 patients with BK viruria lasting at least seven days, hemorrhagic cystitis occurred in 15 (79 percent). The rate of hemorrhagic cystitis was much higher with allogeneic, compared with syngeneic or autologous, HCT (50 versus 7 percent). (See <a href=\"topic.htm?path=overview-of-infections-following-hematopoietic-cell-transplantation#H12425433\" class=\"medical medical_review\">&quot;Overview of infections following hematopoietic cell transplantation&quot;, section on 'Hemorrhagic cystitis'</a>.)</p><p>BK viruria frequently precedes the onset of clinical symptoms, suggesting that viral shedding is not a result of the cystitis [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/5,56\" class=\"abstract_t\">5,56</a>]. BK viremia may be a more specific and independent marker of hemorrhagic cystitis than BK viruria as it indicates more extensive replication and damage [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/57,58\" class=\"abstract_t\">57,58</a>]. Although both intravesicular and intravenous <a href=\"topic.htm?path=cidofovir-drug-information\" class=\"drug drug_general\">cidofovir</a> have been used in patients with BKPyV-associated hemorrhagic cystitis [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/59\" class=\"abstract_t\">59</a>], there have been no controlled trials to evaluate the possible benefit of either approach. Since polyomaviruses do not encode a viral DNA polymerase but recruit the host cell enzyme for this purpose, the selectivity of cidofovir for BKPyV-infected cells is low, and treatment is limited by toxicity.</p><p>Other causes of hemorrhagic cystitis that should be considered in HCT recipients include <a href=\"topic.htm?path=cyclophosphamide-drug-information\" class=\"drug drug_general\">cyclophosphamide</a> toxicity [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/60,61\" class=\"abstract_t\">60,61</a>] and adenovirus infection [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/62,63\" class=\"abstract_t\">62,63</a>]. (See <a href=\"topic.htm?path=general-toxicity-of-cyclophosphamide-in-rheumatic-diseases\" class=\"medical medical_review\">&quot;General toxicity of cyclophosphamide in rheumatic diseases&quot;</a> and <a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-adenovirus-infection\" class=\"medical medical_review\">&quot;Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection&quot;</a> and <a href=\"topic.htm?path=cystitis-in-patients-with-cancer\" class=\"medical medical_review\">&quot;Cystitis in patients with cancer&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H702780718\"><span class=\"h2\">Trichodysplasia spinulosa</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>More recently, TS polyomavirus has been discovered in cytopathic-transforming lesions of trichodysplasia spinulosa, a rare skin disease in immunocompromised patients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/14-16\" class=\"abstract_t\">14-16</a>]. The diagnosis is suggested by the typical clinical features in immunocompromised patients and is confirmed by a skin biopsy with detection of the polyomavirus. In addition to improving immune function (eg, by reducing immunosuppression), topically applied <a href=\"topic.htm?path=cidofovir-drug-information\" class=\"drug drug_general\">cidofovir</a> cream 1% might have a role in therapy of this replicative virus pathology, as described in case reports [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/14,15\" class=\"abstract_t\">14,15</a>].</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Possible associations with malignancies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>JCPyV and BKPyV have been associated with some tumors of the brain, prostate, bladder, and other organs, as evidenced by the presence of viral DNA sequences and the expression of viral proteins in clinical samples [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/64-67\" class=\"abstract_t\">64-67</a>]. BKPyV [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/68\" class=\"abstract_t\">68</a>] and JCPyV can induce tumors in mice and hamsters after experimental inoculation [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/69\" class=\"abstract_t\">69</a>]. Conversely, BKPyV LTag antibody levels and T cell immune responses were associated with a better prognosis of prostate cancer, suggesting that immune response to PyV antigens might be beneficial.</p><p>Despite these reports, a causal relationship between JCPyV or BKPyV infection and the development of malignancies in humans cannot be considered as being fully established [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/70,71\" class=\"abstract_t\">70,71</a>]. The presence of JCPyV genomic DNA in tumors might represent past infection of a progenitor cell that subsequently became malignant through JCPyV-independent mechanisms [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/64,65\" class=\"abstract_t\">64,65</a>].</p><p>By contrast, the role of MCPyV in cases of Merkel cell carcinoma, a rare aggressive neuroendocrine malignancy of the skin, is less disputed. Multiple independent clonal integration sites and the presence of functionally truncating alterations of the viral genome support its etiological role. (See <a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-merkel-cell-neuroendocrine-carcinoma#H5\" class=\"medical medical_review\">&quot;Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma&quot;, section on 'Merkel cell polyomavirus'</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Other possible manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Case reports have suggested an association of polyomaviruses with the following syndromes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Widespread endothelial BKPyV infection in a kidney transplant recipient resulted in severe muscle weakness, anasarca, and a fatal myocardial infarction [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/72\" class=\"abstract_t\">72</a>]. At autopsy, endothelial cells in the heart, skeletal muscles, and esophagus showed transformed nuclei, nuclear inclusions, and apoptosis; PCR testing of kidney, muscle, and heart tissues was positive for BKPyV. Molecular analysis and experimental testing suggested a more virulent BKPyV variant due to constitutive early viral gene expression [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/73\" class=\"abstract_t\">73</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Colonic ulcers were documented in a kidney transplant recipient with abdominal pain and known BKPyV infection of the kidney allograft with associated BK viremia [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/74\" class=\"abstract_t\">74</a>]. Biopsy specimens of the ulcers showed viral inclusion bodies, and in situ hybridization for BKPyV was strongly positive. Reduction in the immunosuppressive regimen led to healing of the ulcers and a decrease in serum BKPyV DNA. Studies for other viruses, including cytomegalovirus, were negative.</p><p/><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">DIAGNOSTIC TESTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of diagnostic tests are used to diagnose infection, replication, and disease caused by human polyomaviruses (HPyVs). The choice of diagnostic test depends upon the clinical setting and the disease manifestations expected. The diagnosis of different polyomavirus (PyV)-associated manifestations is discussed separately. The following discussion provides an overview of the various diagnostic tests.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Urine cytology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Microscopic urine examination can be used to detect cytopathologic changes in urothelial or tubular cells as a sign of high-level urinary shedding of PyVs. The most characteristic abnormality of PyV-infected cells is an enlarged nucleus with large basophilic intranuclear inclusions; such cells are termed &quot;decoy cells&quot; (<a href=\"image.htm?imageKey=ID%2F83969\" class=\"graphic graphic_diagnosticimage graphicRef83969 \">image 1</a>).</p><p>Although there may be characteristic findings suggestive of PyV infection, there are several limitations of cytology:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The cytopathologic changes can be confused at times with those due to malignancy or to other viruses, such as adenovirus.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Urine cytology does not distinguish BK polyomavirus (BKPyV) from JC polyomavirus (JCPyV) [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In kidney transplant recipients, the negative predictive value is high in a dedicated cytology laboratory, making cytology useful for ruling out PyV-associated nephropathy; however, the positive predictive value is low and, when positive, should be followed up by testing for BK viremia [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/4,75,76\" class=\"abstract_t\">4,75,76</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The positive predictive value of decoy cell shedding is increased for PyV-associated nephropathy when persisting for two months or when a decline of more than 20 percent from the baseline renal function is observed [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/6\" class=\"abstract_t\">6</a>].</p><p/><p>Some centers use electron microscopy to look for PyV aggregates in the urine of kidney transplant patients shedding decoy cells, as these aggregates have a higher positive predictive value for PyV-associated nephropathy [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/77,78\" class=\"abstract_t\">77,78</a>].</p><p>The use of urine cytology for the diagnosis of PyV nephropathy is discussed in detail elsewhere. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation#H1216526719\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;, section on 'Urine cytology'</a>.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Polymerase chain reaction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The polymerase chain reaction (PCR) is the test of choice to amplify JCPyV DNA in cerebrospinal fluid (CSF) samples from patients with progressive multifocal leukoencephalopathy (PML). In patients with risk factors and clinical and radiographic signs, the detection of JCPyV in the CSF is considered a laboratory-confirmed diagnosis with a sensitivity of 80 percent and a specificity of more than 95 percent if the assay has a validated sensitivity and specificity and appropriate quantities of CSF has been processed [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/78,79\" class=\"abstract_t\">78,79</a>]. (See <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis#H10\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;, section on 'Diagnosis'</a>.)</p><p>Plasma PCR for JCPyV is less consistently detected in patients with PML or in patients with JCPyV-associated nephropathy. However, PCR detecting persisting high-level JC viruria in the absence of BKPyV in a kidney transplant recipient may be a sign of JCPyV-associated nephropathy [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/6\" class=\"abstract_t\">6</a>].</p><p>Positive results of plasma PCR assays for BKPyV correlate with the presence of PyV-associated nephropathy in kidney transplant recipients and also predict the risk of disease [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/4,23,76\" class=\"abstract_t\">4,23,76</a>]. Withdrawal of immunosuppression and improvement of nephropathy have been correlated with negative plasma PCR assay results. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation#H1216526726\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;, section on 'Quantitative polymerase chain reaction'</a> and <a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a>.)</p><p>PCR is also the most commonly used test for the detection of KI polyomavirus (KIPyV) and WU polyomavirus (WUPyV) in respiratory secretions from transplant recipients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/10,12,80,81\" class=\"abstract_t\">10,12,80,81</a>]. However, the significance of a positive result is unclear since these viruses are detectable in asymptomatic individuals [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/82\" class=\"abstract_t\">82</a>]. Criteria defining proven KIPyV and WUPyV disease are emerging [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/83,84\" class=\"abstract_t\">83,84</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Serology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serum antibodies to PyV indicate past exposure. Antibodies binding to the PyV capsids are most sensitive but do not provide complete protection from ongoing PyV replication in kidney transplant recipients or other immunocompromised hosts.</p><p>For BKPyV and JCPyV, the detection of IgG is taken as evidence of persistent infection and a risk for reactivation but not ongoing disease [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/32,85,86\" class=\"abstract_t\">32,85,86</a>]. Seroconversion or detection of IgM together with increasing IgG titers are interpreted as evidence for recent polyomavirus infection [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/87-90\" class=\"abstract_t\">87-90</a>]. Antibody titers to the polyomavirus large T antigen are generally low but appear to correlate with significant exposure and emerging control of BKPyV replication in kidney transplant recipients with nephropathy [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/87\" class=\"abstract_t\">87</a>].</p><p>JCPyV antibodies may indicate an increased risk for reactivation and PML in multiple sclerosis patients treated with <a href=\"topic.htm?path=natalizumab-drug-information\" class=\"drug drug_general\">natalizumab</a> [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/91\" class=\"abstract_t\">91</a>]. However, detection of JC viruria is common and may independently confirm identifying JCPyV-infected individuals with very low antibody titers [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/92,93\" class=\"abstract_t\">92,93</a>]. However, the absence of JC viruria does not predict a lower risk of PML in these patients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/94\" class=\"abstract_t\">94</a>]. (See <a href=\"topic.htm?path=natalizumab-for-relapsing-remitting-multiple-sclerosis-in-adults#H4\" class=\"medical medical_review\">&quot;Natalizumab for relapsing-remitting multiple sclerosis in adults&quot;, section on 'Risk of PML'</a>.)</p><p>In patients with PML, increasing titers of JCPyV-specific antibodies appear to correlate with a better prognosis [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/95\" class=\"abstract_t\">95</a>].</p><p>Merkel cell polyomavirus&ndash;specific antibodies appear to be higher in patients with Merkel cell carcinoma compared with healthy individuals, indicating significant past exposure, but no protection from this disease [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/96\" class=\"abstract_t\">96</a>]. (See <a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-merkel-cell-neuroendocrine-carcinoma#H5\" class=\"medical medical_review\">&quot;Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma&quot;, section on 'Merkel cell polyomavirus'</a>.)</p><p class=\"headingAnchor\" id=\"H1762144\"><span class=\"h2\">Virus culture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Virus culture is rarely used to detect JCPyV and BKPyV infection outside of the research setting. These viruses grow slowly in tissue culture, and cell lines that are susceptible to PyV infection are not readily available [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/97\" class=\"abstract_t\">97</a>]. The use of tissue culture methods for the growth of the other HPyVs has not been established for diagnostic purposes.</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>BKPyV-associated nephropathy is diagnosed by histopathology. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation#H1216526833\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;, section on 'Histology'</a>.)</p><p>Electron microscopy can be used to detect PyV particles in urinary sediment, in kidney allograft biopsy specimens, and in oligodendrocyte nuclei of brain biopsy specimens. The sensitivity and specificity can be enhanced by combining electron microscopy with hybridization methods [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/37\" class=\"abstract_t\">37</a>] and immunofluorescence [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/98\" class=\"abstract_t\">98</a>] or enzyme-linked immunosorbent assays (ELISAs) [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/99\" class=\"abstract_t\">99</a>].</p><p>In one study, PyV aggregates with the Tamm-Horsfall protein in the urine were observed to have a high positive predictive value for BKPyV-associated nephropathy in kidney transplant recipients [<a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/77\" class=\"abstract_t\">77</a>], but additional studies are needed to confirm its utility.</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomaviruses (HPyVs) are members of a genus of DNA viruses in the Polyomaviridae family. The most common polyomaviruses (PyVs) associated with infectious diseases are JC polyomavirus (JCPyV) and BK polyomavirus (BKPyV). Other polyomaviruses include Merkel cell polyomavirus (MCPyV), as well as TS polyomavirus (TSPyV), KI polyomavirus (KIPyV), and WU polyomavirus (WUPyV). (See <a href=\"topic.htm?path=virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses#H3730944\" class=\"medical medical_review\">&quot;Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses&quot;, section on 'Introduction'</a> and <a href=\"topic.htm?path=virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses#H3730951\" class=\"medical medical_review\">&quot;Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses&quot;, section on 'Classification'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Serologic evidence of past exposure to JCPyV and BKPyV as well as of other HPyVs is widespread, but significant clinical manifestations are rare in immunocompetent hosts. The major clinical manifestations appear to result from reactivation and high-level replication in immunocompromised individuals. (See <a href=\"#H190971454\" class=\"local\">'Disease associations'</a> above and <a href=\"#H3\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In immunocompromised hosts, JCPyV infection can lead to progressive multifocal leukoencephalopathy (PML), a demyelinating disease of high morbidity and mortality. PML has been reported most commonly in patients with advanced HIV infection (particularly before the availability of antiretroviral therapy), but it has also been reported in patients with hematologic malignancies and in patients receiving certain immunosuppressive agents, such as <a href=\"topic.htm?path=natalizumab-drug-information\" class=\"drug drug_general\">natalizumab</a>. (See <a href=\"#H12\" class=\"local\">'Progressive multifocal leukoencephalopathy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>BKPyV can cause nephropathy and ureteral stenosis in kidney transplant recipients and hemorrhagic cystitis in hematopoietic cell transplantation recipients. (See <a href=\"#H190971468\" class=\"local\">'Nephropathy'</a> above and <a href=\"#H190971498\" class=\"local\">'Ureteral stenosis'</a> above and <a href=\"#H13\" class=\"local\">'Hemorrhagic cystitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several other polyomaviruses have been observed less commonly than JCPyV and BKPyV:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>MCPyV infection has been associated with Merkel cell carcinoma. (See <a href=\"#H14\" class=\"local\">'Possible associations with malignancies'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>KIPyV and WUPyV have been detected in respiratory specimens in young children and immunocompromised patients, but their significance is still undefined since they are frequently detected in asymptomatic individuals and may be present together with known pathogens in symptomatic patients. (See <a href=\"#H190971454\" class=\"local\">'Disease associations'</a> above and <a href=\"topic.htm?path=viral-infections-following-lung-transplantation#H1664678137\" class=\"medical medical_review\">&quot;Viral infections following lung transplantation&quot;, section on 'Other community respiratory viruses'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>TSPyV has been associated with trichodysplasia spinulosa, a rare skin disease characterized by spiculae and alopecia in immunocompromised patients. (See <a href=\"#H190971454\" class=\"local\">'Disease associations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A variety of diagnostic tests are used to identify patients at risk and to diagnose diseases caused by PyVs, including the polymerase chain reaction, urine cytology, serology, and histopathology. The choice of diagnostic test depends upon the clinical setting, the patient&rsquo;s risk, and the disease manifestation. (See <a href=\"#H16\" class=\"local\">'Diagnostic tests'</a> above and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis#H10\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation#H14\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=ureteral-stenosis-due-to-bk-virus-infection-among-kidney-transplant-recipients#H6\" class=\"medical medical_review\">&quot;Ureteral stenosis due to BK virus infection among kidney transplant recipients&quot;, section on 'Diagnosis'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H61846105\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Lisa Demeter, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Imperiale MJ, Major EO. Polyomaviruses. In: Fields Virology, 5th ed, Knipe DM, Howley PM (Eds), Lippincott Williams &amp; Wilkins, Philadelpha 2007. Vol 2, p.2263.</li><li class=\"breakAll\">Hirsch HH. Polyoma and Papilloma Virus Infections after Hematopoietic Stem Cell or Solid Organ Transplantation. In: Transplant Infections, Bowden P, Ljungman P, Snydman DR (Eds), Lippincott Williams &amp; Wilkins, 2010. p.465.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/3\" class=\"nounderline abstract_t\">Egli A, Helmersen DS, Taub K, et al. Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. Am J Transplant 2010; 10:2324.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/4\" class=\"nounderline abstract_t\">Hirsch HH, Randhawa P, AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant 2013; 13 Suppl 4:179.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/5\" class=\"nounderline abstract_t\">Arthur RR, Shah KV, Baust SJ, et al. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315:230.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/6\" class=\"nounderline abstract_t\">Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 2007; 84:323.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/7\" class=\"nounderline abstract_t\">Schowalter RM, Pastrana DV, Pumphrey KA, et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010; 7:509.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/8\" class=\"nounderline abstract_t\">Chen T, Hedman L, Mattila PS, et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011; 50:125.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/9\" class=\"nounderline abstract_t\">Venter M, Visser A, Lassauniere R. Human polyomaviruses, WU and KI in HIV exposed children with acute lower respiratory tract infections in hospitals in South Africa. J Clin Virol 2009; 44:230.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/10\" class=\"nounderline abstract_t\">Mourez T, Bergeron A, Ribaud P, et al. Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerg Infect Dis 2009; 15:107.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/11\" class=\"nounderline abstract_t\">Huijskens EG, van Erkel AJ, Peeters MF, Rossen JW. Human polyomavirus KI and WU in adults with community acquired pneumonia in The Netherlands, 2008-2009. J Clin Virol 2010; 49:306.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/12\" class=\"nounderline abstract_t\">Kuypers J, Campbell AP, Guthrie KA, et al. WU and KI polyomaviruses in respiratory samples from allogeneic hematopoietic cell transplant recipients. Emerg Infect Dis 2012; 18:1580.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/13\" class=\"nounderline abstract_t\">Ho J, Jedrych JJ, Feng H, et al. Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. J Infect Dis 2015; 211:1560.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/14\" class=\"nounderline abstract_t\">van der Meijden E, Janssens RW, Lauber C, et al. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog 2010; 6:e1001024.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/15\" class=\"nounderline abstract_t\">Osswald SS, Kulick KB, Tomaszewski MM, Sperling LC. Viral-associated trichodysplasia in a patient with lymphoma: a case report and review. J Cutan Pathol 2007; 34:721.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/16\" class=\"nounderline abstract_t\">van der Meijden E, Horv&aacute;th B, Nijland M, et al. Primary Polyomavirus Infection, Not Reactivation, as the Cause of Trichodysplasia Spinulosa in Immunocompromised Patients. J Infect Dis 2017; 215:1080.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/17\" class=\"nounderline abstract_t\">Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3:611.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/18\" class=\"nounderline abstract_t\">Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009; 9 Suppl 3:S1.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/19\" class=\"nounderline abstract_t\">Hirsch HH, Babel N, Comoli P, et al. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect 2014; 20 Suppl 7:74.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/20\" class=\"nounderline abstract_t\">Zaia J, Baden L, Boeckh MJ, et al. Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009; 44:471.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/21\" class=\"nounderline abstract_t\">Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/22\" class=\"nounderline abstract_t\">Funk GA, Gosert R, Comoli P, et al. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8:2368.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/23\" class=\"nounderline abstract_t\">Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347:488.</a></li><li class=\"breakAll\">Hirsch HH, Vincenti V, Friman S, et al. Risk factors of polyomavirus BKV high-level viruria and viremia in de novo renal transplantation: a multivariate analysis from the DIRECT Study comparing cyclosporine and tacrolimus (Abstract #1664). Transplantation 2010.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/25\" class=\"nounderline abstract_t\">Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7:2727.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/26\" class=\"nounderline abstract_t\">Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5:582.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/27\" class=\"nounderline abstract_t\">Theodoropoulos N, Wang E, Penugonda S, et al. BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation. Am J Transplant 2013; 13:197.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/28\" class=\"nounderline abstract_t\">Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study. Transplantation 2012; 94:814.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/29\" class=\"nounderline abstract_t\">Sharma PM, Gupta G, Vats A, et al. Polyomavirus BK non-coding control region rearrangements in health and disease. J Med Virol 2007; 79:1199.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/30\" class=\"nounderline abstract_t\">Mu&ntilde;oz P, Fogeda M, Bouza E, et al. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect Dis 2005; 41:1720.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/31\" class=\"nounderline abstract_t\">Thomas LD, Milstone AP, Vilchez RA, et al. Polyomavirus infection and its impact on renal function and long-term outcomes after lung transplantation. Transplantation 2009; 88:360.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/32\" class=\"nounderline abstract_t\">Arthur RR, Shah KV, Charache P, Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158:563.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/33\" class=\"nounderline abstract_t\">Giraud G, Priftakis P, Bogdanovic G, et al. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts. Bone Marrow Transplant 2008; 41:737.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/34\" class=\"nounderline abstract_t\">Leung AY, Suen CK, Lie AK, et al. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98:1971.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/35\" class=\"nounderline abstract_t\">Bogdanovic G, Priftakis P, Taemmeraes B, et al. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children. Pediatr Transplant 1998; 2:288.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/36\" class=\"nounderline abstract_t\">Koskenvuo M, Dumoulin A, Lautenschlager I, et al. BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: treatment response and evidence for nosocomial transmission. J Clin Virol 2013; 56:77.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/37\" class=\"nounderline abstract_t\">Markowitz RB, Thompson HC, Mueller JF, et al. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 1993; 167:13.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/38\" class=\"nounderline abstract_t\">Knowles WA, Pillay D, Johnson MA, et al. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 1999; 59:474.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/39\" class=\"nounderline abstract_t\">Sundsfjord A, Osei A, Rosenqvist H, et al. BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis 1999; 180:1.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/40\" class=\"nounderline abstract_t\">Coleman DV, Wolfendale MR, Daniel RA, et al. A prospective study of human polyomavirus infection in pregnancy. J Infect Dis 1980; 142:1.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/41\" class=\"nounderline abstract_t\">McClure GB, Gardner JS, Williams JT, et al. Dynamics of pregnancy-associated polyomavirus urinary excretion: a prospective longitudinal study. J Med Virol 2012; 84:1312.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/42\" class=\"nounderline abstract_t\">Csoma E, S&aacute;py T, M&eacute;sz&aacute;ros B, Gergely L. Novel human polyomaviruses in pregnancy: higher prevalence of BKPyV, but no WUPyV, KIPyV and HPyV9. J Clin Virol 2012; 55:262.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/43\" class=\"nounderline abstract_t\">Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199:837.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/44\" class=\"nounderline abstract_t\">Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342:1309.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/45\" class=\"nounderline abstract_t\">Randhawa P, Uhrmacher J, Pasculle W, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005; 77:238.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/46\" class=\"nounderline abstract_t\">Razonable RR, Brown RA, Humar A, et al. A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis 2005; 192:1349.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/47\" class=\"nounderline abstract_t\">Hirsch HH, Meylan PR, Zimmerli W, et al. HIV-1-infected patients with focal neurologic signs: diagnostic role of PCR for Toxoplasma gondii, Epstein-Barr virus, and JC virus. Clin Microbiol Infect 1998; 4:577.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/48\" class=\"nounderline abstract_t\">Viscidi RP, Khanna N, Tan CS, et al. JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals. Clin Infect Dis 2011; 53:711.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/49\" class=\"nounderline abstract_t\">Khanna N, Elzi L, Mueller NJ, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009; 48:1459.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/50\" class=\"nounderline abstract_t\">Hirsch HH, Kardas P, Kranz D, Leboeuf C. The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS 2013; 121:685.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/51\" class=\"nounderline abstract_t\">Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant 2004; 4:2082.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/52\" class=\"nounderline abstract_t\">Lautenschlager I, Jahnukainen T, Kardas P, et al. A case of primary JC polyomavirus infection-associated nephropathy. Am J Transplant 2014; 14:2887.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/53\" class=\"nounderline abstract_t\">Limaye AP, Smith KD, Cook L, et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant 2005; 5:614.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/54\" class=\"nounderline abstract_t\">Hwang YY, Sim J, Leung AY, et al. BK virus-associated bilateral ureteric stenosis after haematopoietic SCT: viral kinetics and successful treatment. Bone Marrow Transplant 2013; 48:745.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/55\" class=\"nounderline abstract_t\">Khan H, Oberoi S, Mahvash A, et al. Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement. Biol Blood Marrow Transplant 2011; 17:1551.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/56\" class=\"nounderline abstract_t\">Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13:1103.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/57\" class=\"nounderline abstract_t\">Erard V, Storer B, Corey L, et al. BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis. Clin Infect Dis 2004; 39:1861.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/58\" class=\"nounderline abstract_t\">Erard V, Kim HW, Corey L, et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005; 106:1130.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/59\" class=\"nounderline abstract_t\">Cesaro S, Hirsch HH, Faraci M, et al. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis 2009; 49:233.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/60\" class=\"nounderline abstract_t\">Lima MV, Ferreira FV, Macedo FY, et al. Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis. Cancer Chemother Pharmacol 2007; 59:643.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/61\" class=\"nounderline abstract_t\">Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 2007; 23:303.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/62\" class=\"nounderline abstract_t\">Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32:1325.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/63\" class=\"nounderline abstract_t\">Lau GK, Leung YH, Fong DY, et al. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood 2002; 99:2324.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/64\" class=\"nounderline abstract_t\">Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol 2009; 19:252.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/65\" class=\"nounderline abstract_t\">Das D, Shah RB, Imperiale MJ. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene 2004; 23:7031.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/66\" class=\"nounderline abstract_t\">zur Hausen H. Novel human polyomaviruses--re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 2008; 123:247.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/67\" class=\"nounderline abstract_t\">Rollison DE, Helzlsouer KJ, Lee JH, et al. Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev 2009; 18:1515.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/68\" class=\"nounderline abstract_t\">Keller XE, Kardas P, Acevedo C, et al. Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer. Oncotarget 2015; 6:6459.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/69\" class=\"nounderline abstract_t\">Walker DL, Padgett BL, ZuRhein GM, et al. Human papovavirus (JC): induction of brain tumors in hamsters. Science 1973; 181:674.</a></li><li class=\"breakAll\">Dalianis T, Hirsch HH. BK Polyomavirus and Transformation. In: Cancer Associated Viruses, Robertson ES (Ed), Springer-Verlag, New York 2012. p.419.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/71\" class=\"nounderline abstract_t\">Dalianis T, Hirsch HH. Human polyomaviruses in disease and cancer. Virology 2013; 437:63.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/72\" class=\"nounderline abstract_t\">Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001; 345:1250.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/73\" class=\"nounderline abstract_t\">Bethge T, Hachemi HA, Manzetti J, et al. Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression. J Virol 2015; 89:3396.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/74\" class=\"nounderline abstract_t\">Kim GY, Peji J, Nuovo G, Thomas F. BK virus colonic ulcerations. Clin Gastroenterol Hepatol 2004; 2:175.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/75\" class=\"nounderline abstract_t\">Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79:1277.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/76\" class=\"nounderline abstract_t\">Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant 2010; 10:2615.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/77\" class=\"nounderline abstract_t\">Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol 2009; 20:416.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/78\" class=\"nounderline abstract_t\">Masutani K. Current problems in screening, diagnosis and treatment of polyomavirus BK nephropathy. Nephrology (Carlton) 2014; 19 Suppl 3:11.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/79\" class=\"nounderline abstract_t\">Dumoulin A, Hirsch HH. Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms. J Clin Microbiol 2011; 49:1382.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/80\" class=\"nounderline abstract_t\">Bergallo M, Costa C, Terlizzi ME, et al. Quantitative detection of the new polyomaviruses KI, WU and Merkel cell virus in transbronchial biopsies from lung transplant recipients. J Clin Pathol 2010; 63:722.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/81\" class=\"nounderline abstract_t\">Dalianis T, Ramqvist T, Andreasson K, et al. KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol 2009; 19:270.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/82\" class=\"nounderline abstract_t\">van der Zalm MM, Rossen JW, van Ewijk BE, et al. Prevalence and pathogenicity of WU and KI polyomaviruses in children, the Netherlands. Emerg Infect Dis 2008; 14:1787.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/83\" class=\"nounderline abstract_t\">Siebrasse EA, Nguyen NL, Smith C, et al. Immunohistochemical detection of KI polyomavirus in lung and spleen. Virology 2014; 468-470:178.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/84\" class=\"nounderline abstract_t\">Siebrasse EA, Pastrana DV, Nguyen NL, et al. WU polyomavirus in respiratory epithelial cells from lung transplant patient with Job syndrome. Emerg Infect Dis 2015; 21:103.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/85\" class=\"nounderline abstract_t\">Andrews C, Shah KV, Rubin R, Hirsch M. BK papovavirus infections in renal transplant recipients: contribution of donor kidneys. J Infect Dis 1982; 145:276.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/86\" class=\"nounderline abstract_t\">Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 2005; 5:2213.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/87\" class=\"nounderline abstract_t\">Bodaghi S, Comoli P, B&ouml;sch R, et al. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J Clin Microbiol 2009; 47:2577.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/88\" class=\"nounderline abstract_t\">Hariharan S, Cohen EP, Vasudev B, et al. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant 2005; 5:2719.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/89\" class=\"nounderline abstract_t\">Bohl DL, Brennan DC, Ryschkewitsch C, et al. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 2008; 43:184.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/90\" class=\"nounderline abstract_t\">Randhawa P, Bohl D, Brennan D, et al. longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 2008; 15:1564.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/91\" class=\"nounderline abstract_t\">Gorelik L, Lerner M, Bixler S, et al. Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 2010; 68:295.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/92\" class=\"nounderline abstract_t\">Kardas P, Sadeghi M, Weissbach FH, et al. Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays. Clin Vaccine Immunol 2014; 21:1581.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/93\" class=\"nounderline abstract_t\">Kardas P, Leboeuf C, Hirsch HH. Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling. J Clin Virol 2015; 71:28.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/94\" class=\"nounderline abstract_t\">Rudick RA, O'Connor PW, Polman CH, et al. Assessment of JC virus DNA in blood and urine from natalizumab-treated patients. Ann Neurol 2010; 68:304.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/95\" class=\"nounderline abstract_t\">Khanna N, Wolbers M, Mueller NJ, et al. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol 2009; 83:4404.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/96\" class=\"nounderline abstract_t\">Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009; 5:e1000578.</a></li><li class=\"breakAll\">Cinque P, Dumoulin A, Hirsch HH. Diagnosis of Polyomavirus Infection, Replication and Disease. In: Jerome K, Laboratory Diagnosis of Viral Infections (Ed), Informa Healthcare USA, New York 2009. p.401.</li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/98\" class=\"nounderline abstract_t\">Hogan TF, Borden EC, McBain JA, et al. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92:373.</a></li><li><a href=\"https://www.uptodate.com/contents/overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections/abstract/99\" class=\"nounderline abstract_t\">Arthur RR, Beckmann AM, Li CC, et al. Direct detection of the human papovavirus BK in urine of bone marrow transplant recipients: comparison of DNA hybridization with ELISA. J Med Virol 1985; 16:29.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 8280 Version 5.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H22\"><span>SUMMARY</span></a></li><li><a href=\"#H87574322\" id=\"outline-link-H87574322\">INTRODUCTION</a></li><li><a href=\"#H190971454\" id=\"outline-link-H190971454\">DISEASE ASSOCIATIONS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Primary infection</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Viruria</a><ul><li><a href=\"#H6\" id=\"outline-link-H6\">- Transplant recipients</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- HIV-infected patients</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Systemic lupus erythematosus</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Pregnancy</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Healthy individuals</a></li></ul></li><li><a href=\"#H101903165\" id=\"outline-link-H101903165\">Viremia</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Progressive multifocal leukoencephalopathy</a></li><li><a href=\"#H190971468\" id=\"outline-link-H190971468\">Nephropathy</a></li><li><a href=\"#H190971498\" id=\"outline-link-H190971498\">Ureteral stenosis</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Hemorrhagic cystitis</a></li><li><a href=\"#H702780718\" id=\"outline-link-H702780718\">Trichodysplasia spinulosa</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Possible associations with malignancies</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Other possible manifestations</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">DIAGNOSTIC TESTS</a><ul><li><a href=\"#H18\" id=\"outline-link-H18\">Urine cytology</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Polymerase chain reaction</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Serology</a></li><li><a href=\"#H1762144\" id=\"outline-link-H1762144\">Virus culture</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Other</a></li></ul></li><li><a href=\"#H22\" id=\"outline-link-H22\">SUMMARY</a></li><li><a href=\"#H61846105\" id=\"outline-link-H61846105\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/8280|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83969\" class=\"graphic graphic_diagnosticimage\">- BK virus decoy cells</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cystitis-in-patients-with-cancer\" class=\"medical medical_review\">Cystitis in patients with cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-toxicity-of-cyclophosphamide-in-rheumatic-diseases\" class=\"medical medical_review\">General toxicity of cyclophosphamide in rheumatic diseases</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=natalizumab-for-relapsing-remitting-multiple-sclerosis-in-adults\" class=\"medical medical_review\">Natalizumab for relapsing-remitting multiple sclerosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-infections-following-hematopoietic-cell-transplantation\" class=\"medical medical_review\">Overview of infections following hematopoietic cell transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-merkel-cell-neuroendocrine-carcinoma\" class=\"medical medical_review\">Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-epidemiology-and-clinical-manifestations-of-adenovirus-infection\" class=\"medical medical_review\">Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-treatment-and-prognosis\" class=\"medical medical_review\">Progressive multifocal leukoencephalopathy: Treatment and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ureteral-stenosis-due-to-bk-virus-infection-among-kidney-transplant-recipients\" class=\"medical medical_review\">Ureteral stenosis due to BK virus infection among kidney transplant recipients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=viral-infections-following-lung-transplantation\" class=\"medical medical_review\">Viral infections following lung transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses\" class=\"medical medical_review\">Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses</a></li></ul></div></div>","javascript":null}